-
New MJFF Report Details Advances in Biochemical Biomarker Research
March 5, 2026
… As part of our commitment to advancing the diagnosis, treatment and prevention of Parkinson’s disease … measurable molecules, like proteins or enzymes, that allow researchers and healthcare providers to test for presence of … They may also be used to identify people with Parkinson’s early in their disease progression, with the goal of one day …
-
Critical Targets in Parkinson’s Disease Research
August 19, 2012
… As the world's largest private funder of Parkinson's research, The Michael J. Fox Foundation (MJFF) is dedicated …
-
Double Your Dollars for Research this Giving Tuesday
… means your donation will be doubled for twice the impact on research. Here’s everything you need to know about how the … works, and more importantly, how it will impact Parkinson’s research. What is Giving Tuesday? Giving Tuesday is a … More than 46,000 people have shared information online and nearly 100,000 have completed smell tests through our remote …
-
Patient Data Advancing Parkinson's Disease Biomarker Research
October 3, 2017
… Advancements in technology provide researchers opportunities to collect real-time, continuous … doctors get from patients at appointments and enable researchers to develop more efficient Parkinson's clinical … such as watches, could give doctors valuable understandings into the ways Parkinson's affects patients in their daily …
-
Targeting GBA1 for Parkinson's disease research
October 21, 2015
… Boston, MA; 4The Jackson Laboratory, Bar Harbor, ME; 5WIL Research, Ashland, OH; 6NeuroScience Associates, Knoxville, … MJFF's vision is to apply a holistic strategy to address research and therapeutic chalemenges to enable accelerated …
-
Phase II Study of Isradipine as a Disease-modifying Agent in Early Parkinson's Disease
… study (called STEADY-PD) will recruit 100 patients with early PD who are not yet taking any medications to treat PD … if isradipine slows progression of PD. Relevance to Diagnosis/Treatment of Parkinson ’s Disease: Currently, … window for treatments aimed at lessening the symptoms in early-stage PD patients, improving their quality of life. …